Brian D Kiluk1, Charla Nich, Kathleen M Carroll. 1. Department of Psychiatry, Division of Substance Abuse, Yale University School of Medicine, 950 Campbell Avenue, 151D, West Haven, Connecticut 06516, USA. brian.kiluk@yale.edu
Abstract
OBJECTIVE: This study sought to determine the extent to which key aspects of a clinical trial's protocol were recalled by participants entering a clinical trial for alcohol and illicit substance-use treatment after standard informed-consent procedures, as well as to explore the possible relationships between recall, neuropsychological functioning, and substance-use outcomes. METHOD: Before entering a randomized clinical trial testing the effectiveness of a computer-based training version of cognitive-behavioral therapy, 76 participants (55% male) meeting criteria for current substance dependence (according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) completed a 14-item true/false quiz that assessed their comprehension of basic information provided in the consent form. RESULTS: Only 15% of participants correctly answered all 14 consent quiz items. The percentage of correct recall was associated with measures of intelligence (r= .29, p = .01) and attention (r = -.26, p = .04). Quiz scores were also moderately associated with the amount of substance use during the treatment period (r = -.26, p = .03). CONCLUSIONS: These findings highlight the importance of formally evaluating research participants' understanding of the informed-consent process, and they call to attention the potential utility of a brief neuropsychological screening to identify individuals in need of enhanced consent procedures, particularly within vulnerable populations, such as substance users.
RCT Entities:
OBJECTIVE: This study sought to determine the extent to which key aspects of a clinical trial's protocol were recalled by participants entering a clinical trial for alcohol and illicit substance-use treatment after standard informed-consent procedures, as well as to explore the possible relationships between recall, neuropsychological functioning, and substance-use outcomes. METHOD: Before entering a randomized clinical trial testing the effectiveness of a computer-based training version of cognitive-behavioral therapy, 76 participants (55% male) meeting criteria for current substance dependence (according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) completed a 14-item true/false quiz that assessed their comprehension of basic information provided in the consent form. RESULTS: Only 15% of participants correctly answered all 14 consent quiz items. The percentage of correct recall was associated with measures of intelligence (r= .29, p = .01) and attention (r = -.26, p = .04). Quiz scores were also moderately associated with the amount of substance use during the treatment period (r = -.26, p = .03). CONCLUSIONS: These findings highlight the importance of formally evaluating research participants' understanding of the informed-consent process, and they call to attention the potential utility of a brief neuropsychological screening to identify individuals in need of enhanced consent procedures, particularly within vulnerable populations, such as substance users.
Authors: Kathleen M Carroll; Samuel A Ball; Steve Martino; Charla Nich; Theresa A Babuscio; Kathryn F Nuro; Melissa A Gordon; Galina A Portnoy; Bruce J Rounsaville Journal: Am J Psychiatry Date: 2008-05-01 Impact factor: 18.112
Authors: Ashleigh A Allen; Donna T Chen; Richard J Bonnie; Tomohiro M Ko; Colleen E Suratt; Joshua D Lee; Peter D Friedmann; Michael Gordon; Ryan McDonald; Sean M Murphy; Tamara Y Boney; Edward V Nunes; Charles P O'Brien Journal: J Subst Abuse Treat Date: 2017-08-01
Authors: Ryan D McDonald; Babak Tofighi; Eugene Laska; Keith Goldfeld; Wanda Bonilla; Mara Flannery; Nadina Santana-Correa; Christopher W Johnson; Neil Leibowitz; John Rotrosen; Marc N Gourevitch; Joshua D Lee Journal: Contemp Clin Trials Date: 2016-05-10 Impact factor: 2.226
Authors: Mia Malone; Ryan McDonald; Alex Vittitow; Jenny Chen; Rita Obi; Daniel Schatz; Babak Tofighi; Ann Garment; Andrea Kermack; Keith Goldfeld; Heather Gold; Eugene Laska; John Rotrosen; Joshua D Lee Journal: Contemp Clin Trials Date: 2019-04-12 Impact factor: 2.226
Authors: Marilyn E Coors; Kristen M Raymond; Christian J Hopfer; Joseph Sakai; Shannon K McWilliams; Susan Young; Susan K Mikulich-Gilbertson Journal: Drug Alcohol Depend Date: 2015-12-21 Impact factor: 4.492